Varnimcabtagene autoleucel (ARI‐0001) in relapsed or refractory mantle cell lymphoma

Abstract Varnimcabtagene autoleucel (var‐cel) is an autologous CD19‐directed chimeric antigen receptor (CAR) T‐cell therapy administered using an adaptive, fractionated dosing strategy. We conducted a multicenter retrospective study to evaluate the safety and efficacy of var‐cel in patients with rel...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Nil Albiol, Nuria Martínez‐Cibrián, Amanda Isabel Pérez, Sergio Navarro‐Velázquez, Guilherme Muzzi, Aina Oliver‐Caldes, Marta Español‐Rego, Leticia Alserawan, Mercedes Montoro‐Lorite, Carla Ramos, Pilar Ayora, Ana África Martin‐López, Almudena Cabero, Estefanía Pérez‐López, Alejandro Martín García‐Sancho, Tycho Baumann, José María Sánchez‐Pina, Anabelle Chinea, Paula Fernández‐Caldas, Mariana Bastos‐Oreiro, Mi Kwon, Luis Gerardo Rodríguez‐Lobato, Laura Magnano, Andrea Rivero, Juan G. Correa, Pablo Mozas, María Sánchez‐Castañón, Juan J. Mata‐Molanes, Paola Charry, Jose R. Álamo, Xavier Setoaín, Sonia Rodríguez, Eulalia Olesti, Joaquín Sáez‐Peñataro, Carlos Fernández de Larrea, Álvaro Urbano‐Ispizua, Armando López‐Guillermo, Julio Delgado, E. Azucena González‐Navarro, Manel Juan, Eva Giné, Valentín Ortiz‐Maldonado
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2026-05-01
Serija:	HemaSphere
Online dostop:	https://doi.org/10.1002/hem3.70388
Oznake:	Označite Brez oznak, prvi označite!